General Information of Drug (ID: DMD9U5Q)

Drug Name
IMA 203 Drug Info
Indication
Disease Entry ICD 11 Status REF
Hematologic tumour 2B33.Y Phase 1 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMD9U5Q

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
IMC-F106C DMHQ2U8 Solid tumour/cancer 2A00-2F9Z Phase 1/2 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tumor expressed melanoma antigen (PRAME) TTPH7T0 PRAME_HUMAN Not Available [1]

References

1 Clinical pipeline report, company report or official report of Immatics.
2 Clinical pipeline report, company report or official report of Immunocore.